CVSI
CV Sciences, Inc.
+0.00 (+30.00%)0.01USD150成交股數2.9M市值–本益比(近四季)0.2股價營收比-17.5%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 3.0M-18% | 3.2M-11% | 3.3M-14% | 3.3M-18% | 3.6M-10% | 3.6M-5% | 3.9M-5% | 4.0M-0% | 4.0M | 3.8M | 4.1M | 4.0M |
| 營業成本 | 1.5M | 1.6M | 1.6M | 1.7M | 1.8M | 1.9M | 2.1M | 2.1M | 2.1M | 2.1M | 2.2M | 2.2M |
| 毛利 | 1.5M-21% | 1.6M-6% | 1.7M-6% | 1.6M-15% | 1.8M-0% | 1.7M-5% | 1.8M-4% | 1.9M+8% | 1.9M | 1.7M | 1.8M | 1.7M |
| 毛利率 | 48.6% | 48.9% | 50.5% | 48.5% | 50.9% | 46.0% | 46.0% | 47.0% | 46.3% | 45.8% | 45.1% | 43.3% |
| 研發費用 | 18K | 18K | 18K | 24K | 50K | 30K | 29K | 28K | 36K | 40K | 40K | 36K |
| 銷售管理費用 | 1.7M | 1.9M | 1.7M | 1.8M | 1.9M | 2.1M | 2.1M | 2.4M | 2.4M | 2.6M | 2.2M | 2.8M |
| 營業利益 | −301K+130% | −318K-2991% | −75K-78% | −275K-53% | −131K-79% | 11K-101% | −341K-22% | −583K-46% | −620K | −889K | −437K | −1.1M |
| 營業利益率 | -10.1% | -10.0% | -2.3% | -8.4% | -3.6% | 0.3% | -8.8% | -14.7% | -15.5% | -23.4% | -10.7% | -27.1% |
| 稅後淨利 | −775K+197% | −643K+490% | −206K-55% | −382K-35% | −261K-58% | −109K-87% | −456K+2% | −584K-55% | −628K | −869K | −447K | −1.3M |
| 淨利率 | -26.0% | -20.1% | -6.2% | -11.7% | -7.2% | -3.0% | -11.8% | -14.8% | -15.7% | -22.9% | -10.9% | -32.5% |
| 稀釋 EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00-100% | 0.00 | 0.00-100% | 0.00 | -0.01 | 0.00 | -0.01 |
| 稀釋股數 | 205M | 187M | 184M | 184M | 184M | 184M | 182M | 172M | 163M | 154M | 155M | 153M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 266K | 309K | 278K | 381K | 886K | 812K | 979K | 477K | 662K | 1.3M | 1.6M | 1.7M |
| 應收帳款 | 348K | 391K | 402K | 405K | 545K | 430K | 422K | 639K | 507K | 431K | 666K | 611K |
| 存貨 | 4.0M | 3.9M | 4.1M | 4.1M | 4.2M | 4.4M | 5.0M | 5.2M | 5.8M | 5.7M | 5.7M | 5.8M |
| 總資產 | 6.5M | 6.7M | 7.0M | 7.0M | 8.0M | 7.8M | 8.4M | 8.9M | 8.5M | 9.2M | 9.6M | 9.9M |
| 有息負債 | 0 | 0 | 387K | 504K | 208K | 498K | – | – | – | – | – | – |
| 總負債 | 5.0M | 5.2M | 5.5M | 5.5M | 6.1M | 5.9M | 6.2M | 6.4M | 6.1M | 6.3M | 6.2M | 6.0M |
| 股東權益 | 1.6M | 1.5M | 1.5M | 1.5M | 1.8M | 1.9M | 2.2M | 2.5M | 2.4M | 2.9M | 3.5M | 3.9M |
| 負債比 | 75.9% | 77.7% | 78.9% | 78.0% | 77.3% | 75.6% | 73.9% | 71.8% | 72.1% | 68.4% | 63.9% | 60.6% |
| 淨現金(現金 − 有息負債) | 266K | 309K | −109K | −123K | 678K | 314K | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 101K-225% | – | – | – | −81K | – | – | −518K | – | – | – |
| 資本支出 | – | 3K | – | – | – | 40K | – | – | 0 | – | – | – |
| 自由現金流 | – | 98K-181% | – | – | – | −121K | – | – | −518K | – | – | – |
| 折舊攤銷 | – | 23K | – | – | – | 82K | – | – | 63K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 3.1% | – | – | – | -3.4% | – | – | -12.9% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 13.8M | -12.2% | −958K | -6.9% | -0.01 | −516K |
| FY2024 | 15.7M | -1.9% | −2.4M | -15.2% | -0.01 | −879K |
| FY2023 | 16.0M | -1.2% | 3.1M | 19.4% | 0.02 | 2.3M |
| FY2022 | 16.2M | -19.2% | −8.2M | -50.7% | -0.07 | −1.9M |
| FY2021 | 20.0M | -17.9% | −15.6M | -77.6% | -0.14 | −7.5M |
| FY2020 | 24.4M | -54.5% | −22.3M | -91.2% | -0.22 | −8.4M |
| FY2019 | 53.7M | +11.3% | −16.6M | -30.9% | -0.17 | −3.4M |
| FY2018 | 48.2M | – | 10.0M | 20.7% | 0.09 | 11.7M |